Outcome of COVID-19 Vaccination Trials for Children under 12

Debated in Parliament on 11 Jan 2022.

Summary written by AI (learn more)

Sharael Taha inquired about the outcomes of COVID-19 vaccination trials for children under 12, the percentage who developed side effects, and whether certain groups were more susceptible.
Ong Ye Kung responded that the matter had already been addressed in a prior oral reply on January 10, 2022, directing attention to the Official Report on the assessment of vaccine effects and decisions for younger children.
The debate did not introduce new information beyond referencing the existing official report and oral answers.

Questions identified by AI (learn more)

Full Transcript

Sharael Taha

Mr Sharael Taha asked the Minister for Health (a) what was the outcome of the COVID-19 vaccination trials for children under 12; (b) what percentage of these children developed side effects; and (c) whether particular groups of these children are more susceptible to the side effects.

Ong Ye Kung

This question for written answer has been addressed by oral reply to Question Nos 13 to 15 on the Order Paper for 10 January 2022. [Please refer to "Assessment of Effects of COVID-19 Vaccines on Younger Children and Singapore's Decision to Extend Vaccination to Younger Children", Official Report, 10 January 2022, Vol 95, Issue 44, Oral Answers to Questions section.]

Summary written by AI (learn more)

Sharael Taha inquired about the outcomes of COVID-19 vaccination trials for children under 12, the percentage who developed side effects, and whether certain groups were more susceptible.
Ong Ye Kung responded that the matter had already been addressed in a prior oral reply on January 10, 2022, directing attention to the Official Report on the assessment of vaccine effects and decisions for younger children.
The debate did not introduce new information beyond referencing the existing official report and oral answers.

Questions identified by AI (learn more)

Outcome of COVID-19 Vaccination Trials for Children under 12 | PAPERCUTS

Outcome of COVID-19 Vaccination Trials for Children under 12

Debated in Parliament on 11 Jan 2022.

Summary written by AI (learn more)

Sharael Taha inquired about the outcomes of COVID-19 vaccination trials for children under 12, the percentage who developed side effects, and whether certain groups were more susceptible.
Ong Ye Kung responded that the matter had already been addressed in a prior oral reply on January 10, 2022, directing attention to the Official Report on the assessment of vaccine effects and decisions for younger children.
The debate did not introduce new information beyond referencing the existing official report and oral answers.

Questions identified by AI (learn more)

Full Transcript

Sharael Taha

Ong Ye Kung

Summary written by AI (learn more)

Sharael Taha inquired about the outcomes of COVID-19 vaccination trials for children under 12, the percentage who developed side effects, and whether certain groups were more susceptible.
Ong Ye Kung responded that the matter had already been addressed in a prior oral reply on January 10, 2022, directing attention to the Official Report on the assessment of vaccine effects and decisions for younger children.
The debate did not introduce new information beyond referencing the existing official report and oral answers.

Questions identified by AI (learn more)

Outcome of COVID-19 Vaccination Trials for Children under 12

Summary

Questions Identified

Full Transcript

Sharael Taha

Ong Ye Kung

Summary

Questions Identified

Outcome of COVID-19 Vaccination Trials for Children under 12

Summary

Questions Identified

Full Transcript

Sharael Taha

Ong Ye Kung

Summary

Questions Identified